CALL FOR ABSTRACT SUBMISSIONS
SCIENTIFIC PROGRAMME COMMITTEE
Vice-Chair, Medicines for Europe, Biosimilar Medicines Group; Head of Clinical Development of Biologics, Gedeon Richter Plc.
Vice Chair, Department Clinical Pharmacology, Medical University of Vienna
Associate Professor, Section for Medical Statistics, Medical Unversity of Vienna
Statistician, Austrian Medicines and Medical Devices Agency; President, Viennese Section of IBS
Chief Scientific Officer, Accelsiors CRO Ltd.; President, Hungarian Society for Clinical Biostatistics
Director Biostatistics for Biostatistics Biosimilars, Analytics group, Novartis
This two-day series of events consists of a COURSE DAY with two professional lecture sessions (October 25th) and a SYMPOSIUM DAY (invited presentations, posters and round table session, scheduled for October 26th) comprising issues in biosimilar development with strong FOCUS ON Statistical and Regulatory Perspectives.
25th October, 2018 | COURSES with special lecturers
26th October, 2018 | SYMPOSIUM and ROUND TABLE
SPEAKERS AND LECTURERS
As in previous years, the program of the event will be supported and complemented by international specialists from the biosimilars and nanosimilars area. The programme of the event will continue to expand until October with internationally renowned subject experts. Some specialists who accepted the invitation to participate at the 3rd Annual Biosimilars Forum:
Professor Emeritus from the University of Toronto; Former President of Canadian Society for Pharmaceutical Scientists
European Regulatory Expert; Unit Head, Austrian Medicines and Medical Devices Agency
Owner, BEBAC – Consultancy Services for Bioequivalence and Bioavailability Studies
Ludwig A. HOTHORN
Professor of Biostatistics at Leibniz Universität Hannover, Faculty of Natural Sciences, Hannover, Germany
Professor of Statistics, Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics, Lancaster University, UK
Deputy Director Research Design and Conduct Service and Research Fellow, Cardiff University, UK
Director of the Nanomedicine Research and Education Center of Semmelweis Medical University, Budapest
Tickets are available now with flexible terms. Please send us your registration as soon as possible because places are limited in number! WBS and ISCB members can attend the 2nd day symposium for free.
Registration deadline: 15th October, 2018
1st day COURSES with special lecturers
Bring the Regulators and Producer Companies together into one room is an excellent idea and a beautiful concept.
–Bernd JILMA | Vice Chair, Department Clinical Pharmacology, Medical University of Vienna
I think it’s very nicely covers the whole biosimilar development process… Broader roles could benefit from this conference!
–Ildikó ARADI | Head of Clinical Development of Biologics, Gedeon Richter Plc.
These conferences are extremely useful, they provide discussions in many problems and issues. I hope very much that the series will continue …
–László ENDRÉNYI | Professor Emeritus of Pharmacology and Biostatistics, University of Toronto
The Organizers really done a very good job trying to put together such a conference where we can exchange an idea regarding the regulatory approval process and also on some actual issues in the biosimilar drug development process.
–Shein-Chung CHOW | Professor, Duke University School of Medicine
These meetings, where experts are coming together from the same or different countries bring something new: collaborations, new knowledge, so this is very precious.
–János SZEBENI | Director of the Nanomedicine Research and Education Center at Semmelweis University